Statement of Changes in Beneficial Ownership (4)
February 28 2023 - 6:07PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Cordani David |
2. Issuer Name and Ticker or Trading Symbol
Cigna Group
[
CI
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chairman & CEO |
(Last)
(First)
(Middle)
900 COTTAGE GROVE ROAD |
3. Date of Earliest Transaction
(MM/DD/YYYY)
2/24/2023 |
(Street)
BLOOMFIELD, CT 06002
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock, $.01 Par Value | 2/24/2023 | | A | | 37549.0000 (1) | A | $0.0000 | 160351.0000 | D | |
Common Stock, $.01 Par Value | 2/24/2023 | | F | | 2306.0000 (2) | D | $294.2700 | 158045.0000 | D | |
Common Stock, $.01 Par Value | 2/24/2023 | | F | | 17401.0000 (3) | D | $294.2700 | 140644.0000 | D | |
Common Stock, $.01 Par Value | 2/27/2023 | | S(4) | | 20148.0000 | D | $294.0600 | 120496.0000 | D | |
Common Stock, $.01 Par Value | | | | | | | | 1697.3913 (5) | I | By 401(k) |
Common Stock, $.01 Par Value | | | | | | | | 376643.0000 | I | By GRAT |
Common Stock, $.01 Par Value | | | | | | | | 90495.0000 | I | By Trust |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
(1) | The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2020-2022 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. |
(2) | Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. |
(3) | Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. |
(4) | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14 , 2022. |
(5) | Represents shares acquired through ongoing participation in Cigna's 401(k) Plan. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Cordani David 900 COTTAGE GROVE ROAD BLOOMFIELD, CT 06002 | X |
| Chairman & CEO |
|
Signatures
|
Kevin Ciaglo, attorney-in-fact | | 2/28/2023 |
**Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
Cigna (NYSE:CI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cigna (NYSE:CI)
Historical Stock Chart
From Sep 2023 to Sep 2024